Literature DB >> 11899242

The human ATP-binding cassette transporter genes: from the bench to the bedside.

T Efferth1.   

Abstract

ATP-binding cassette (ABC) transporter genes are ubiquitously present in most organisms from bacteria to man. This gene family is the largest one known as of yet. Still growing, the number of human ABC transporters counts currently 47 members which belong to seven subfamilies. ABC transporters share a similar molecular architecture: (1) Full-structured transporters harbor two symmetric halves each consisting of one nucleotide binding domain (NBD) and one transmembrane domain (TMD). (2) Half-transporters with one NBD and one TMD homo- or heterodimerize to functional transporter complexes. ABC transporters are "traffic ATPases" which hydrolyze ATP and which transport a wide array of molecules or conduct the transport of molecules by stimulating other translocation mechanisms. Many ABC transporters are involved in human inherited or sporadic diseases such as cystic fibrosis, adrenoleukodystrophy, Stargardt's disease, drug-resistant tumors, Dubin-Johnson syndrome, Byler's disease, progressive familiar intrahepatic cholestasis, X-linked sideroblastic anemia and ataxia, persistent hyperinsulimenic hypoglycemia of infancy, and others. The present review summarizes the current findings in basic research and the efforts for bridging the gap to clinical applications in therapy and diagnostics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899242     DOI: 10.2174/1566524013364194

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  27 in total

1.  Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation.

Authors:  Nuha Mahmoud; Mohamed E M Saeed; Yoshikazu Sugimoto; Sabine M Klauck; Henry J Greten; Thomas Efferth
Journal:  Oncotarget       Date:  2018-11-06

2.  Resistance mechanisms of cancer cells to the novel vacuolar H(+)-ATPase inhibitor archazolid B.

Authors:  Rebecca Hamm; Yoshikazu Sugimoto; Heinrich Steinmetz; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-07-29       Impact factor: 3.850

Review 3.  Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.

Authors:  Armelle T Mbaveng; Victor Kuete; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-06-02       Impact factor: 5.810

4.  Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids.

Authors:  Marco Mrusek; Ean-Jeong Seo; Henry Johannes Greten; Michael Simon; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-10-25       Impact factor: 3.850

Review 5.  Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals.

Authors:  Onat Kadioglu; Jingming Cao; Mohamed E M Saeed; Henry Johannes Greten; Thomas Efferth
Journal:  Target Oncol       Date:  2014-11-21       Impact factor: 4.493

6.  Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cells.

Authors:  Victor Kuete; Louis P Sandjo; Doriane E Djeussi; Maen Zeino; Guy M N Kwamou; Bonaventure Ngadjui; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-07-19       Impact factor: 3.850

7.  Externalization of phosphatidylserine via multidrug resistance 1 (MDR1)/P-glycoprotein in oxalate-treated renal epithelial cells: implications for calcium oxalate urolithiasis.

Authors:  Yu-Hang Li; Shi-Liang Yu; Xiu-Guo Gan; Shang-Ha Pan; Yue-Qiu Teng; Rui-Hua An
Journal:  Int Urol Nephrol       Date:  2015-11-11       Impact factor: 2.370

Review 8.  Transport processes of radiopharmaceuticals and -modulators.

Authors:  Thomas Efferth; Peter Langguth
Journal:  Radiat Oncol       Date:  2011-06-06       Impact factor: 3.481

9.  Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.

Authors:  Serkan Sertel; Margaret Tome; Margaret M Briehl; Judith Bauer; Kai Hock; Peter K Plinkert; Thomas Efferth
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

Review 10.  Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites.

Authors:  Mahmoud Zaki El-Readi; Ahmed M Al-Abd; Mohammad A Althubiti; Riyad A Almaimani; Hiba Saeed Al-Amoodi; Mohamed Lotfy Ashour; Michael Wink; Safaa Yehia Eid
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.